Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03809585 · ClinicalTrials.gov registry record
Observational Study of Iris Tumors
A clinical trial of Iris Tumor, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT03809585: Recruiting study of Iris Tumor, sponsored by Oregon Health and Science University.
NCT03809585 is a study of Iris Tumor that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03809585, a study of Iris Tumor, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study using OCT angiography to assist with tumor characterization in melanotic and amelanotic iris lesions. OCT angiography data from healthy eyes will be compared to eyes with various types of iris tumors.
Conditions Studied
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-06-20 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03809585
The ClinicalTrials.gov registry entry for NCT03809585 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Iris Tumor appearing as the primary indexed condition, and to 0 interventions.
NCT03809585 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT03809585 about?
NCT03809585 is a clinical study titled "Observational Study of Iris Tumors". This is an observational study using OCT angiography to assist with tumor characterization in melanotic and amelanotic iris lesions. OCT angiography data from healthy eyes will be compared to eyes with various types of iris tumors.
What is the current status of trial NCT03809585?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2018-06-20. Estimated completion is 2027-12.
What conditions does trial NCT03809585 study?
This clinical trial studies the following conditions: Iris Tumor.
Who is sponsoring clinical trial NCT03809585?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03809585 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.